Title: FDA Drug Safety Reporting Protocol

Document ID: PHARMA-FDA-2024-001

Regulatory Framework:
- 21 CFR Part 312 (IND Safety Reporting)
- 21 CFR Part 314 (NDA Safety Reporting)
- 21 CFR Part 11 (Electronic Records)

Safety Reporting Timelines:
- Fatal/Life-threatening: 7 days initial, 8 days follow-up
- Serious unexpected: 15 days
- Annual safety reports: 60 days from IND anniversary

Data Retention:
- Adverse event data logs in secure repositories
- Retention period: Product lifetime + 10 years minimum
- Electronic and paper records maintained

Compliance Requirements:
- Data residency must comply with 21 CFR Part 11
- Electronic signatures and audit trails required
- System validation documented
- Regular compliance audits

Applies to: Clinical, Regulatory, QA teams
